![SciELO - Brasil - Intravenous iron therapy: how far have we come? Intravenous iron therapy: how far have we come? SciELO - Brasil - Intravenous iron therapy: how far have we come? Intravenous iron therapy: how far have we come?](https://minio.scielo.br/documentstore/1806-0870/s8KyBJpRzZM4pCgCvf4wfZM/ebb30590f0abc47fbe6e9e94bc9f428efcd30cd3.jpg)
SciELO - Brasil - Intravenous iron therapy: how far have we come? Intravenous iron therapy: how far have we come?
![Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trial - Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trial -](https://www.thelancet.com/cms/asset/c7df5a2a-8630-4a1e-87a6-4ea7ac28a2fa/gr1.jpg)
Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trial -
Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management | Haematologica
![Table 2 from Improving efficiency and value in health care. Intravenous iron management for anaemia associated with chronic kidney disease: linking treatment to an outpatient clinic, optimizing service provision and patient choice. Table 2 from Improving efficiency and value in health care. Intravenous iron management for anaemia associated with chronic kidney disease: linking treatment to an outpatient clinic, optimizing service provision and patient choice.](https://d3i71xaburhd42.cloudfront.net/043b2a5ba28a40e47902d8e39c10bafc324dabd6/2-Table1-1.png)
Table 2 from Improving efficiency and value in health care. Intravenous iron management for anaemia associated with chronic kidney disease: linking treatment to an outpatient clinic, optimizing service provision and patient choice.
The Iron Clinic - IRON THERAPY in the USA. Tablet dose should be 65mg elemental iron a day (the compund total is often >200mg so you have to read the label). Note
![Ferric carboxymaltose infusion versus oral iron supplementation for preoperative iron deficiency anaemia in patients with colorectal cancer (FIT): a multicentre, open-label, randomised, controlled trial - The Lancet Haematology Ferric carboxymaltose infusion versus oral iron supplementation for preoperative iron deficiency anaemia in patients with colorectal cancer (FIT): a multicentre, open-label, randomised, controlled trial - The Lancet Haematology](https://www.thelancet.com/cms/attachment/769e1f47-bcd6-4847-bf81-cd80c61920f1/gr1_lrg.jpg)
Ferric carboxymaltose infusion versus oral iron supplementation for preoperative iron deficiency anaemia in patients with colorectal cancer (FIT): a multicentre, open-label, randomised, controlled trial - The Lancet Haematology
![Safety and effectiveness of intravenous iron sucrose versus standard oral iron therapy in pregnant women with moderate-to-severe anaemia in India: a multicentre, open-label, phase 3, randomised, controlled trial - The Lancet Global Safety and effectiveness of intravenous iron sucrose versus standard oral iron therapy in pregnant women with moderate-to-severe anaemia in India: a multicentre, open-label, phase 3, randomised, controlled trial - The Lancet Global](https://www.thelancet.com/cms/attachment/2a2fa596-48ae-4415-a12e-f4b7c6d2ebf9/gr1_lrg.gif)